Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-02

Clinical Trial Update: Confirming the Accuracy of Endoscopic Marking Using a New Marker, a Novel Luminomarker, in Lesion Marking Before Colorectal Cancer Surgery. [NA]

View source ↗

Summary

This clinical trial evaluates the accuracy of a novel luminomarker for endoscopic lesion marking before colorectal cancer surgery and is enrolling by invitation…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Novel Luminomarker (Luminomarker)

Snippet

Sponsor: Seoul St. Mary's Hospital | Conditions: Colorectal Cancer, Endoscopic Tattoo of Suspected Colon Cancer | NA | Status: ENROLLING_BY_INVITATION